Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 23 | Robbins Edward Hutchinson Jr.EVP, General Counsel | Tax withholding | F | $741K 134.0K sh | Feb 4, 2026 |
| 23 | Frew JamesSEE REMARKS | Option exercise | M | — 50.6K sh | Feb 4, 2026 traded Feb 1, 2026 |
| 23 | Ruppel DavidSVP & GM Transportation Bus. | Option exercise | M | $280K 1,113 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 23 | Bernstein HaroldPresident, R&D & CMO | Open-market sale · 10b5-1 plan | SELL | $4,723 100 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 22 | Frew JamesSEE REMARKS | Tax withholding | F | $100K 19.9K sh | Feb 4, 2026 traded Feb 1, 2026 |
| 22 | Stiles Spencer SPresident and COO | Tax withholding | F | $2.83M 7,692 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 22 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | Open-market sale · 10b5-1 plan | SELL | $558K 2,415 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 22 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | Open-market sale · 10b5-1 plan | SELL | $272K 1,179 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 22 | Moore Alexander D.Director | Open-market sale · 10b5-1 plan | SELL | $374K 2,525 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 22 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $308K 1,334 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 22 | Moore Alexander D.Director | Open-market sale · 10b5-1 plan | SELL | $942K 6,310 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 22 | Robinson-Gay DonaldSenior Vice President | Other acquisition or disposition | J | $1,549 25 sh | Feb 4, 2026 traded Dec 31, 2025 |
| 22 | Smith Michael AlexanderChief Legal Officer | Open-market sale | SELL | $100K 640 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 22 | Bendza Gary MarkEVP, CFO | Tax withholding | F | $1.21M 219.3K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Honorable Colette DEVP CLO Compliance & Corp Sec | Option exercise | M | — 3,872 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Mat IshbiaDirector, President and CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $3.20M 632.9K sh | Feb 4, 2026 traded Feb 4, 2026 |
| 21 | Binioris Savvas Steve PanagiotisEVP and Chief Risk Officer | Grant or award | A | — 24.8K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Mat IshbiaDirector, President and CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $3.30M 632.9K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 21 | Ghingo John FDirector, President | Grant or award | A | — 32.7K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Kleczynski Robert ASVP, Controller & Tax | Option exercise | M | — 2,110 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Honorable Colette DEVP CLO Compliance & Corp Sec | Option exercise | M | — 4,781 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Smith NathanChief Financial Officer | Grant or award | A | — 33.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Honorable Colette DEVP CLO Compliance & Corp Sec | Option exercise | M | — 4,781 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Robbins Edward Hutchinson Jr.EVP, General Counsel | Grant or award | A | — 270.4K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Shaikh KashifDirector, President and CEO | Grant or award | A | — 137.9K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Cota GermaineChief Accting. Off. & VP, Fin. | Grant or award | A | — 21.8K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Jones Jeanne MEVP, CFO, Audit & Risk | Option exercise | M | — 7,031 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Robinson-Gay DonaldSenior Vice President | Grant or award | A | — 2,800 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 21 | Meng JessicaChief Commercial Officer | Grant or award | A | — 60.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Ruppel DavidSVP & GM Transportation Bus. | Option exercise | M | — 1,113 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Howze YalondaINTERIM CEO & PRESIDENT | Option exercise | M | — 1,673 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 21 | Gutman CarrieSenior Vice President | Grant or award | A | — 1,620 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 21 | Raub ChristopherExecutive Vice President | Grant or award | A | — 4,179 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 20 | Schladen JamesPresident of Arcadia | Tax withholding | F | $69K 8,053 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 20 | Detz Margaret MasonerChief People Officer | Grant or award | A | $125K 1,422 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 20 | Malenka Robert C.Director | Open-market sale | SELL | $127K 7,039 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 20 | Schwartz Richard ToddDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $4.35M 247.1K sh | Feb 4, 2026 traded Feb 4, 2026 |
| 20 | Koetje Todd MSee Remarks. | Grant or award | A | $193K 2,198 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 19 | Duffy Kristine DDirector | Grant or award | A | $27K 818 sh | Feb 4, 2026 traded Jan 28, 2026 |
| 19 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $378K 1,639 sh | Feb 4, 2026 traded Feb 3, 2026 |